I have done some thinking. I believe things are progressing well and the changes were well accepted with no people hurt and the company perhaps positioned to be more aggressive in its timeline to secure a deal in the medium term.
What I do believe is that Mr. Tribe is no idiot. A pure business professional with a huge investor network which will compliment the Hockings expertise in medicine with PWs and RH's past work with PYC. This added to the excellent reputation of Mr. Hayes leads me to believe that this is a real attempt to progress the company towards commercialisation. I am sure the next quarterly, which should be soon will further validate the belief the board has with the science. The rest of you know far more than I do concerning the science!
I have spoken to Stephanie a few time during her tenure and always found her approachable and an excellent communicator to stakeholders. So we should all wish her well with future ventures she may undertake.
I sold 2 million yesterday and regret doing so now. I think this has legs I really do. DOYR
PYC Price at posting:
3.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)